J&J announces data to support boosting its single-shot COVID-19 vaccine
“New data shows that a booster dose of the Johnson & Johnson COVID-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination, among clinical trial participants.”